Novelgenix Therapeutics Private Limited, a active private limited company, was established on 20 June 2011 in Ahmedabad, Gujarat, India. Engaging in pharma contract r&d within the professional, scientific and technical sector, it holds CIN: U74140GJ2011PTC065969. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹1.50 Cr and a paid-up capital of ₹0.18 M.
It upholds a compliant status. Its leadership includes Monika Kamalnain Verma (Director), Harsh Shivprakash Rathnam (Director), Shivprakash Chinnappa (Managing Director). Past directors included Monika Kamalnain Verma, Harsh Shivprakash Rathnam, Shivprakash Chinnappa. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at 405A,Pinnacle,Corporate Road, Prahaladnagar,Satellite, Ahmedabad, Gujarat, 380015.
U74140GJ2011PTC065969
065969
20 June 2011
₹1.50 Cr
₹0.18 M
Roc Ahmedabad
Unlisted
Active
Explore comprehensive insights into Novelgenix Therapeutics Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Monika Kamalnain Verma | Director | 20 Jun 2011 | Current |
| Harsh Shivprakash Rathnam | Director | 09 Jun 2022 | Current |
| Shivprakash Chinnappa | Managing Director | 20 Jun 2011 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 12 Apr 2019 | Past |
| Pramod Abcsdd | Additional Director | 27 Sep 2022 | Past |
| Pramod Abcsdd | Director | 01 Oct 2015 | Past |
| Pramod Abcsdd | Director | 07 Jun 2022 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Novelgenix Therapeutics Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 95.89% decrease. The company also saw a slight improvement in profitability, with a 6.23% increase in profit. The company's net worth observed a substantial decline by a decrease of 3080.52%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Novelgenix Therapeutics had a public holding of 16.22%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Novelgenix Therapeutics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Novelgenix Therapeutics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Novelgenix Therapeutics's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Novelgenix Therapeutics Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was recorded as a recent event.
Novelgenix Therapeutics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad. was recorded as a recent event.
Harsh Shivprakash Rathnam was appointed as a Director was appointed as a Director on 09 Jun 2022 & has been associated with this company since 3 years 7 months . was recorded as a recent event.
Monika Kamalnain Verma was appointed as a Director was appointed as a Director on 20 Jun 2011 & has been associated with this company since 14 years 6 months . was recorded as a recent event.
Progress on Shivprakash Chinnappa was appointed as a Managing Director was appointed as a Managing Director on 20 Jun 2011 & has been associated with this company since 14 years 6 months . was documented.
Novelgenix Therapeutics Private Limited was registered on 20 Jun 2011 with Roc Ahmedabad & aged 14 years 6 months as per MCA records. was recorded as a recent event.
The CIN of Novelgenix Therapeutics Private Limited is U74140GJ2011PTC065969.
Novelgenix Therapeutics Private Limited is headquartered at 405A,Pinnacle,Corporate Road, Prahaladnagar,Satellite, Ahmedabad, Gujarat, 380015.
Novelgenix Therapeutics Private Limited was incorporated on 20 June 2011.
The current directors of Novelgenix Therapeutics Private Limited are
The primary industry of Novelgenix Therapeutics Private Limited is Professional, Scientific And Technical.
Novelgenix Therapeutics Private Limited is unlisted.
The authorized capital of Novelgenix Therapeutics Private Limited is ₹1.50 Cr, and the paid-up capital is ₹0.18 M.
The compliance status of Novelgenix Therapeutics Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX